By Shida Chayesteh COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, will on Tuesday seek to reassure investors that its outlook is intact, analysts said ahead of the company's capital markets day (CMD). "We expect it will act as a strong confidence booster for Novo's future growth prospects," Nordea analyst Michael Novod wrote in a note to clients, adding that he didn't expect major new announcements. Analysts generally expect Novo Nordisk to reiterate its 2014 guidance and its long-term financial targets of 15 percent annual growth in operating earnings, a 40 percent operating margin and a cash conversion of 90 percent.
via Health News Headlines - Yahoo! News http://news.yahoo.com/preview-denmarks-novo-seen-reinforcing-growth-plans-analysts-113709527--finance.html
No comments:
Post a Comment